gw8510 has been researched along with su 9516 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckner, FS; Domostoj, MM; Gelb, MH; Gillespie, JR; Napuli, AJ; Ojo, KK; Riechers, AJ; Scheer, A; Van Voorhis, WC; Verlinde, CL; Wells, SJ; Wells, TN | 1 |
| Gucký, T; Hendrychová, D; Jorda, R; Kryštof, V; Řezníčková, E; Voller, J | 1 |
2 other study(ies) available for gw8510 and su 9516
| Article | Year |
|---|---|
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
Topics: Animals; Base Sequence; DNA Primers; DNA, Protozoan; Genes, Protozoan; Glycogen Synthase Kinase 3; Humans; Models, Molecular; Protein Kinase Inhibitors; Recombinant Proteins; RNA Interference; Species Specificity; Trypanosoma brucei brucei; Trypanosomiasis, African | 2008 |
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
Topics: Cell Cycle; Cyclin-Dependent Kinases; HCT116 Cells; Humans; Protein Kinase Inhibitors; Quinolines; Thiazoles | 2018 |